Sensus Healthcare, Inc. (SRTS): Cost of Revenue
$15.62M
Year ended 2025-12-31
$11.14M
Trailing 12 months to 2026-06-30
+1.6%
3-year compound annual growth
+29.3%
5-year compound annual growth
+15.5%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.62M | -10.1% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $17.38M | +68.0% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $10.35M | -30.6% | 2025-03-05, From 2023-01-01 |
| 2022-12-31 | $14.90M | +48.2% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $10.05M | +132.3% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $4.33M | -55.4% | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | $9.71M | +2.0% | 2021-03-05, From 2019-01-01 |
| 2018-12-31 | $9.52M | +40.2% | 2020-03-06, From 2018-01-01 |
| 2017-12-31 | $6.79M | +36.7% | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | $4.97M | +34.5% | 2018-02-15, From 2016-01-01 |
| 2015-12-31 | $3.69M | n/a | 2017-03-10, From 2015-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $15.62M | -10.1% |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $28.49M | +55.2% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $190.0K | -6.9% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $3.65M | -16.7% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $9.69M | -29.6% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $14.28M | +16.4% |
| Cytosorbents Corp (CTSO) | 2025-12-31 | $10.57M | -1.3% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $38.22M | +12.2% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $10.72M | -34.2% |
Compare SRTS, PREM, OBIO, BDMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗